Fulgent Genetics (FLGT) Change in Account Payables (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Change in Account Payables for 11 consecutive years, with $924000.0 as the latest value for Q4 2025.
- Quarterly Change in Account Payables rose 214.36% to $924000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $550000.0 through Dec 2025, down 82.06% year-over-year, with the annual reading at $550000.0 for FY2025, 82.06% down from the prior year.
- Change in Account Payables hit $924000.0 in Q4 2025 for Fulgent Genetics, up from -$102000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $7.0 million in Q4 2022 to a low of -$22.1 million in Q3 2022.
- Historically, Change in Account Payables has averaged -$2.0 million across 5 years, with a median of -$451500.0 in 2024.
- Biggest YoY gain for Change in Account Payables was 318.23% in 2022; the steepest drop was 1860.21% in 2022.
- Year by year, Change in Account Payables stood at -$3.2 million in 2021, then soared by 318.23% to $7.0 million in 2022, then plummeted by 98.16% to $129000.0 in 2023, then crashed by 726.36% to -$808000.0 in 2024, then soared by 214.36% to $924000.0 in 2025.
- Business Quant data shows Change in Account Payables for FLGT at $924000.0 in Q4 2025, -$102000.0 in Q3 2025, and $386000.0 in Q2 2025.